Neurological outcomes after hematopoietic stem cell transplantation for cerebral X-linked adrenoleukodystrophy, late onset metachromatic leukodystrophy and hurler syndrome;Desfechos neurológicos após transplante de células tronco hematopoiéticas na adrenoleucodistrofia ligada ao X, forma cerebral, na leucodistrofia metacromática de início tardio e na síndrome de hurler

Arquivos de Neuro-Psiquiatria

Volumn 74, Issue 12, 2016, Pages 953-966

  Saute, Jonas Alex Morales ^a,b   De Souza, Carolina Fischinger Moura ^a   De Oliveira Poswar, Fabiano ^b   Donis, Karina Carvalho ^a,b   Campos, Lillian Gonçalves ^a,b   Deyl, Adriana Vanessa Santini ^a   Burin, Maira Graeff ^a   Vargas, Carmen Regla ^a,b   Da Silveira Matte, Ursula ^a,b   Giugliani, Roberto ^a,b   Saraiva Pereira, Maria Luiza ^a,b   Vedolin, Leonardo Modesti ^a,b   Gregianin, Lauro José ^a,b   Jardim, Laura Bannach ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adrenoleukodystrophy; Hematopoietic stem cell transplantation; Leukodystrophy; Metachromatic; Mucopolysaccharidosis I

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; SULFATIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HURLER SYNDROME; MALE; METACHROMATIC LEUKODYSTROPHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; X LINKED LINKED CEREBRAL ADRENOLEUKODYSTROPHY; ADULT; BRAIN; BRAZIL; CASE REPORT; DIAGNOSTIC IMAGING; DONOR; EPIDEMIOLOGY; GENETICS; LEUKODYSTROPHY, METACHROMATIC; MORTALITY; MUCOPOLYSACCHARIDOSIS I; ONSET AGE; PATHOLOGY; PEDIGREE; PRESCHOOL CHILD; PROCEDURES; TRANSPLANTATION CONDITIONING; WHITE MATTER; YOUNG ADULT;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; AGE OF ONSET; BRAIN; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKODYSTROPHY, METACHROMATIC; MAGNETIC RESONANCE IMAGING; MALE; MUCOPOLYSACCHARIDOSIS I; PEDIGREE; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; WHITE MATTER; YOUNG ADULT;

EID: 85006333154     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282x20160155     Document Type: Article

References (35)

1. Krall WJ, Challita PM, Perlmutter LS, Skelton DC, Kohn DB. Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation. Blood. 1994; 83(9): 2737-48.
2. Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M et al. Late-onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology. 2006; 67(5): 859-63. doi: 10.1212/01.wnl.0000234129.97727.4d
3. Cable C, Finkel RS, Lehky TJ, Biassou NM, Wiggs EA, Bunin N et al. Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings. Mol Genet Metab. 2011; 102(2): 207-9. doi: 10.1016/j.ymgme.2010.10.002
4. Martin HR, Poe MD, Provenzale JM, Kurtzberg J, Mendizabal A, Escolar ML et al. Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. Biol Blood Marrow Transplant. 2013; 19(4): 616-24. doi: 10.1016/j.bbmt.2013.01.010
5. Solders M, Martin DA, Andersson, Remberger M, Andersson T, Ringdén O et al. Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy. Bone Marrow Transplant. 2014; 49(8): 1046-51. doi: 10.1038/bmt.2014.93
6. Beam D, Poe MD, Provenzale JM, Szabolcs P, Martin PL, Prasad V et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant. 2007; 13(6): 665-74. doi: 10.1016/j.bbmt.2007.01.082
7. Miller WP, Rothman SM, Nascene D, Kivisto T, DeFor TE, Ziegler RS et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood. 2011; 118(7): 1971-8. doi: 10.1182/blood-2011-01-329235
8. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood. 1998; 91(7): 2601-8.
9. Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011; 6(1): 55. doi: 10.1186/1750-1172-6-55
10. Groeschel S, Kühl JS, Bley AE, Kehrer C, Weschke B, Döring M et al. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients. JAMA Neurol. 2016; 73(9): 1133-40. doi: 10.1001/jamaneurol.2016.2067
11. Boelens JJ, Prasad VK, Tolar J, Wynn RF, Peters C. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am. 2010; 57(1): 123-45. doi: 10.1016/j.pcl.2009.11.004
12. Musolino PL, Lund TC, Pan J, Escolar ML, Paker AM, Duncan CN et al. Hematopoietic stem cell transplantation in the leukodystrophies: a systematic review of the literature. Neuropediatrics. 2014; 45(3): 169-74. doi: 10.1055/s-0033-1364179
13. Aldenhoven M, Boelens JJ, Koning TJ. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant. 2008; 14(5): 485-98. doi: 10.1016/j.bbmt.2008.01.009
14. Poe MD, Chagnon SL, Escolar ML. Early treatment is associated with improved cognition in Hurler syndrome. Ann Neurol. 2014; 76(5): 747-53. doi: 10.1002/ana.24246
15. Engelen M, Kemp S, Visser M, Geel BM, Wanders RJ, Aubourg P et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012; 7(1): 51. doi: 10.1186/1750-1172-7-51
16. Boucher AA, Miller W, Shanley R, Ziegler R, Lund T, Raymond G. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis. 2015; 10(1): 94. doi: 10.1186/s13023-015-0313-y
17. Jardim LB, Silva AC, Blank D, Villanueva MM, Renck L, Costa ML et al. X-linked adrenoleukodystrophy: clinical course and minimal incidence in South Brazil. Brain Dev. 2010; 32(3): 180-90. doi: 10.1016/j.braindev.2009.02.002
18. Moser HW, Moser AB. Measurement of saturated very long chain fatty acid in plasma. In: Hommes FA, editor. Techniques of diagnostic human biochemical genetics. Wiley, New York. 1991, pp. 177-191.
19. Virgens MY, Siebert M, Bock H, Burin M, Giugliani R, Saraiva-Pereira ML. Genotypic characterization of Brazilian patients with infantile and juvenile forms of metachromatic leukodystrophy. Gene. 2015; 568(1): 69-75. doi: 10.1016/j.gene.2015.05.016
20. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman L et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol. 1994; 15(9): 1761-6.
21. Eichler F, Grodd W, Grant E, Sessa M, Biffi A, Bley A et al. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol. 2009; 30(10): 1893-7. doi: 10.3174/ajnr.A1739
22. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood. 1987; 70(5): 1382-8.
23. Cartier N, Aubourg P. Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy. Curr Opin Mol Ther. 2008; 10(5): 471-8. doi:
24. Jardim LB, Villanueva MM, Souza CF, Netto CB. Clinical aspects of neuropathic lysosomal storage disorders. J Inherit Metab Dis. 2010; 33(4): 315-29. doi: 10.1007/s10545-010-9079-5
25. Lange MC, Teive HAG, Troiano AR, Bitencourt M, Funke VA, Setúbal DC et al. Bone marrow transplantation in patients with storage diseases: a developing country experience. Arq Neuropsiquiatr. 2006; 64(1): 1-4. doi: 10.1590/S0004-282X2006000100001
26. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood. 2004; 104(3): 881-8. doi: 10.1182/blood-2003-10-3402
27. Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013; 121(19): 3981-7. doi: 10.1182/blood-2012-09-455238
28. Fitzpatrick AS, Loughrey CM, Johnston P, McKee S, Spence W, Flynn et al. Haematopoietic stem-cell transplant for adult cerebral adrenoleukodystrophy. Eur J Neurol. 2008; 15(3): e21-2. doi: 10.1111/j.1468-1331.2007.02048.x
29. Ding X-Q, Bley A, Kohlschütter A, Fiehler J, Lanfermann H. Long-term neuroimaging follow-up on an asymptomatic juvenile metachromatic leukodystrophy patient after hematopoietic stem cell transplantation: evidence of myelin recovery and ongoing brain maturation. Am J Med Genet A. 2012; 158A(1): 257-60. doi: 10.1002/ajmg.a.34389
30. Krägeloh-Mann I, Groeschel S, Kehrer C, Opherk K, Nägele T, Handgretinger R et al. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort. Bone Marrow Transplant. 2013; 48(3): 369-75. doi: 10.1038/bmt.2012.155
31. Egmond ME, Pouwels PJW, Boelens JJ, Lindemans CA, Barkhof F, Steenwijk MD et al. Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy. JAMA Neurol. 2013; 70(6): 779-82. doi: 10.1001/jamaneurol.2013.629
32. Smith NJ, Marcus RE, Sahakian BJ, Kapur N, Cox TM. Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy. J Inherit Metab Dis. 2010; 33(s3): S471-5. doi: 10.1007/s10545-010-9240-1
33. Oussoren E, Keulemans J, Diggelen OP, Oemardien LF, Timmermans RG, Ploeg AT et al. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients. Mol Genet Metab. 2013; 109(4): 377-81. doi: 10.1016/j.ymgme.2013.05.016
34. Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Semin Hematol. 2010; 47(1): 59-69. doi: 10.1053/j.seminhematol.2009.10.008
35. Shapiro E, Guler OE, Rudser K, Delaney K, Bjoraker K, Whitley C et al. An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol Genet Metab. 2012; 107(1-2): 116-21. doi: 10.1016/j.ymgme.2012.07.016